share_log

Why HOOKIPA Pharma (HOOK) Stock Is Volatile Today

Why HOOKIPA Pharma (HOOK) Stock Is Volatile Today

爲什麼hookipa pharma (HOOK)股票今天波動較大
Benzinga ·  07/08 12:17

HOOKIPA Pharma Inc (NASDAQ:HOOK) shares are trading lower by 10.9% to $0.50 during Monday's session after the company announced a 1-for-10 reverse stock split, effective at 5:00 p.m. ET on July 9. The stock will start trading on a split-adjusted basis on July 10.

HOOKIPA Pharma(納斯達克:HOOK)股票在週一交易中下跌10.9%至0.50美元,原因是該公司宣佈進行1:10的股票拆分,將於7月9日下午5:00生效。股票將於7月10日在經過拆分調整後開始交易。

This move aims to meet Nasdaq's minimum bid price requirement for continued listing. Post-split, every 10 shares will be consolidated into one share, maintaining the same par value per share. Fractional shares will not be issued; instead, stockholders will receive a cash payment for any fractional shares.

此舉旨在滿足納斯達克的最低買盤價格要求。拆分後,每10股將合併爲1股,保持每股的同等面值。不會發行碎股,而是股東將收到任何碎股的現金支付。

Read Also: French Luxury Stocks Fall As Tax Concerns Rise After Left-Wing Election Upset

法國奢侈品股票在左翼選舉慘敗後,稅收問題升溫導致市場下跌。

How To Buy HOOK Stock

如何買入 HOOk 股票

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

除了手動到經紀所平台購買股票或者部分股票,您還可以通過購買持有股票的ETF,或者在401(k)中分配資金進入一項該類基金或其他工具的策略來獲得股票的份額。例如,Coinbase屬於金融部門。ETF通常持有許多能跟蹤該部門的流動性和大型公司的股票,使投資者能夠獲得該股票板塊內的趨勢。

For example, in HOOKIPA Pharma's case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

例如,在HOOKIPA Pharma的情況下,它屬於醫療保健板塊。ETF通常會持有許多流動性和大型公司的股票,這些公司有助於跟蹤該板塊,從而使投資者能夠獲得該領域內的趨勢曝光。

According to data from Benzinga Pro, HOOK has a 52-week high of $1.13 and a 52-week low of $0.41.

根據Benzinga Pro的數據,HOOk的52周最高價爲1.13美元,52周最低價爲0.41美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論